wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q39190208-22DC9269-3BB1-4BAB-8565-C9C0EF2D0BA0
Q39190208-22DC9269-3BB1-4BAB-8565-C9C0EF2D0BA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39190208-22DC9269-3BB1-4BAB-8565-C9C0EF2D0BA0
Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates.
P2860
Q39190208-22DC9269-3BB1-4BAB-8565-C9C0EF2D0BA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39190208-22DC9269-3BB1-4BAB-8565-C9C0EF2D0BA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
24ac7f4ac5c2f839dc6cad445e593a5f5b5c38d7
P2860
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial